Potential pitfalls on the road to an effective HIV vaccine
- 28 February 1994
- journal article
- review article
- Published by Elsevier in Immunology Today
- Vol. 15 (2) , 54-57
- https://doi.org/10.1016/0167-5699(94)90133-3
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- A Strategy for Prophylactic Vaccination Against HIVScience, 1993
- The HIV-1 Nef protein shares an antigenic determinant with a T-cell surface proteinAIDS, 1993
- A TH1→TH2 switch is a critical step in the etiology of HIV infectionImmunology Today, 1993
- Anti-CD4 Antibodies are Associated with HIV-1 Seroconversion and May Be Detectable Before Anti-HIV-1 AntibodiesAIDS Research and Human Retroviruses, 1992
- Changes in T-helper cell function in human immunodeficiency virus- infected children during didanosine therapy as a measure of antiretroviral activityBlood, 1992
- Anti-CD4 Anti-Idiotype Antibodies in Volunteers Immunized with rgp 160 of HIV-1 or Infected with HIV-1AIDS Research and Human Retroviruses, 1992
- High Titers of Cytopathic Virus in Plasma of Patients with Symptomatic Primary HIV-1 InfectionNew England Journal of Medicine, 1991
- Structural Homology Between HIV-1tatProtein and Various Human ProteinsAIDS Research and Human Retroviruses, 1990
- Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals.Journal of Clinical Investigation, 1989
- Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta 1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome.The Journal of Experimental Medicine, 1988